1082 related articles for article (PubMed ID: 33138853)
21. Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease.
Casillas AC; Barragan VA; Alhalaseh Y; Modi MB; Lake E; Speiser JJ
J Cutan Pathol; 2023 Oct; 50(10):864-868. PubMed ID: 37430411
[TBL] [Abstract][Full Text] [Related]
22. Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J; Schwartz RA
J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
[TBL] [Abstract][Full Text] [Related]
23. Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation.
Girijala RL; Siddiqi I; Kwak Y; Wright D; Patel DB; Goldberg LH
J Drugs Dermatol; 2019 Feb; 18(2):207-209. PubMed ID: 30811149
[TBL] [Abstract][Full Text] [Related]
24. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.
Mockenhaupt M
Semin Cutan Med Surg; 2014 Mar; 33(1):10-6. PubMed ID: 25037254
[TBL] [Abstract][Full Text] [Related]
25. Severe adverse drug reactions.
Teo YX; Walsh SA
Clin Med (Lond); 2016 Feb; 16(1):79-83. PubMed ID: 26833523
[TBL] [Abstract][Full Text] [Related]
26. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
27. Deadly drug rashes: Early recognition and multidisciplinary care.
Jaroenpuntaruk V; Gray A
Cleve Clin J Med; 2023 Jun; 90(6):373-381. PubMed ID: 37263663
[TBL] [Abstract][Full Text] [Related]
28. Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report.
Luo F; Yuan XM; Xiong H; Chen CM; Ma WK; Yao XM
Medicine (Baltimore); 2023 Nov; 102(47):e36168. PubMed ID: 38013380
[TBL] [Abstract][Full Text] [Related]
29. Acute Generalized Exanthematous Pustulosis: Clinical Characteristics, Pathogenesis, and Management.
Stadler PC; Oschmann A; Kerl-French K; Maul JT; Oppel EM; Meier-Schiesser B; French LE
Dermatology; 2023; 239(3):328-333. PubMed ID: 36702114
[TBL] [Abstract][Full Text] [Related]
30. Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
Nili A; Zarei E; Ghamari A; Farid AS; Tavakolpour S; Daneshpazhooh M; Mahmoudi H
Int Immunopharmacol; 2020 Dec; 89(Pt B):107093. PubMed ID: 33091817
[TBL] [Abstract][Full Text] [Related]
31. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
33. Acute generalized exanthematous pustulosis induced by piroxicam: a case report.
Cherif Y; Jallouli M; Mseddi M; Turki H; Bahloul Z
Indian J Pharmacol; 2014; 46(2):232-3. PubMed ID: 24741202
[TBL] [Abstract][Full Text] [Related]
34. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
35. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
[No Abstract] [Full Text] [Related]
36. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
[TBL] [Abstract][Full Text] [Related]
37. Facts, not Fear: Safety of Hydroxychloroquine.
Kuraitis D; Murina A
Am J Med Sci; 2020 Aug; 360(2):199-200. PubMed ID: 32560964
[No Abstract] [Full Text] [Related]
38. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
39. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.
Parisi R; Shah H; Navarini AA; Muehleisen B; Ziv M; Shear NH; Dodiuk-Gad RP
Am J Clin Dermatol; 2023 Jul; 24(4):557-575. PubMed ID: 37156992
[TBL] [Abstract][Full Text] [Related]
40. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
